Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies

被引:62
作者
Friedland, Gerald
Harries, Anthony
Coetzee, David
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect,AIDS Program, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Epidemiol, Infect Dis Sect,AIDS Program, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Dept Publ Hlth, Infect Dis Sect,AIDS Program, New Haven, CT 06520 USA
[4] Minist Hlth, Clin HIV Unit, Lilongwe, Malawi
[5] Malawi Country Off, Family Hlth Int, Lilongwe, Malawi
[6] London Sch Hyg & Trop Med, London WC1, England
[7] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Infect Dis Epidemiol Unit, ZA-7700 Rondebosch, South Africa
关键词
D O I
10.1086/518664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The many interactions between tuberculosis (TB) and human immunodeficiency virus (HIV) infection influence the design and implementation of programs to address the needs of patients living with or at risk for both diseases. Collaboration between national TB and HIV programs and some degree of integration of services at a local level have been advocated by the World Health Organization and other international bodies and are recognized as essential in areas where the 2 diseases are prevalent. However, in most settings, strategies to accomplish this are only beginning to reach the field where their impact will be made and the expectation of improving the outcome of both diseases realized. In this article, 3 such strategies, offering varying degrees of collaboration and integration, are described, 1 at a national level in Malawi and 2 at local sites in South Africa. These geographically and programmatically distinct experiences in TB/HIV service integration are instructive, illustrate common themes, and show that the strategy can be successful, but they also show that programmatic, medical, staffing, resource, and scale-up challenges remain. In addition, they indicate that, although broad program principles of TB/HIV service integration are essential, program designs and components may vary by country and even within countries, as a result of differing TB and HIV disease prevalences, resources, levels of expertise, and differences in program settings (urban vs. rural and/or primary vs. district vs. specialty site). Large national programs can successfully provide rapid, uniform and widespread change and implementation but also must negotiate the subtleties of intricacies of TB/HIV interactions, which confound a uniform "one size fits all" public health approach. Conversely, smaller demonstration projects, even with successful outcomes, must grapple with issues related to generalization of findings, wider implementation, and scale up, to benefit larger populations of those in need.
引用
收藏
页码:S114 / S123
页数:10
相关论文
共 42 条
[1]   Tuberculosis in HIV-infected patients:: a comprehensive review [J].
Aaron, L ;
Saadoun, D ;
Calatroni, I ;
Launay, O ;
Mémain, N ;
Vincent, V ;
Marchal, G ;
Dupont, B ;
Bouchaud, O ;
Valeyre, D ;
Lortholary, O .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (05) :388-398
[2]  
[Anonymous], 2003, Treatment of tuberculosis: guidelines for national programmes, V3rd
[3]   Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment [J].
Bock, Naomi N. ;
Jensen, Paul A. ;
Miller, Bess ;
Nardell, Edward .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 :S108-S113
[4]   Efficacy and safety of two dosages of cotrimoxazole as preventive treatment for HIV-infected Malawian adults with new smear-positive tuberculosis [J].
Boeree, MJ ;
Sauvageot, D ;
Banda, HT ;
Harries, AD ;
Zijlstra, EE .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2005, 10 (08) :723-733
[5]  
BOULLE A, 2004, 15 INT AIDS C BANGK
[6]  
*CAPRISA DIV AIDS, 2004, START START TUB ANT
[7]  
*CDCP AM THOR SOC, 2003, AM J RESP CRIT CARE, V167, P306
[8]  
Chimzizi R, 2005, REPORT COUNTRY WIDE
[9]   Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controled trial [J].
Chintu, C ;
Bhat, GJ ;
Walker, AS ;
Mulenga, V ;
Sinyinza, F ;
Lishimpi, K ;
Farrelly, L ;
Kaganson, N ;
Zumla, A ;
Gillespie, SH ;
Nunn, AJ ;
Gibb, DM .
LANCET, 2004, 364 (9448) :1865-1871
[10]   Integrating tuberculosis and HIV care in the primary care setting in South Africa [J].
Coetzee, D ;
Hilderbrand, K ;
Goemaere, E ;
Matthys, F ;
Boelaert, M .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (06) :A11-A15